Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

[A new era of transfusion-transmitted pathogens, infections. Renewed need for updating standards for clinicans along with blood banking].

Udvardy M.

Orv Hetil. 2018 Sep;159(37):1495-1500. doi: 10.1556/650.2018.31183. Review. Hungarian.

PMID:
30196714
2.

Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation.

Palyu E, Harsfalvi J, Tornai T, Papp M, Udvardy M, Szekeres-Csiki K, Pataki L, Vanhoorelbeke K, Feys HB, Deckmyn H, Tornai I.

Thromb Haemost. 2018 Aug;118(8):1397-1408. doi: 10.1055/s-0038-1661393. Epub 2018 Jul 4.

3.

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT.

Gagelmann N, Eikema DJ, Iacobelli S, Koster L, Nahi H, Stoppa AM, Masszi T, Caillot D, Lenhoff S, Udvardy M, Crawley C, Arcese W, Mariette C, Hunter A, Leleu X, Schipperus M, Delforge M, Pioltelli P, Snowden JA, Itälä-Remes M, Musso M, van Biezen A, Garderet L, Kröger N.

Haematologica. 2018 May;103(5):890-897. doi: 10.3324/haematol.2017.178434. Epub 2018 Feb 1.

4.

[Treatment of relapsed Hodgkin lymphoma after autologous stem cell transplantation].

Illés Á, Simon Z, Udvardy M, Magyari F, Jóna Á, Miltényi Z.

Orv Hetil. 2017 Aug;158(34):1338-1345. doi: 10.1556/650.2017.30823. Hungarian.

PMID:
28823212
5.

[Activated Factor VII - 31 years experience on clinical grounds].

Udvardy M.

Orv Hetil. 2017 Jun;158(24):923-928. doi: 10.1556/650.2017.30758. Review. Hungarian.

PMID:
28604077
6.

[Hungarian Philadelphia negative chronic myeloproliferative neoplasia registry. Evaluation of the Polycythemia vera patients].

Dombi P, Illés Á, Demeter J, Homor L, Simon Z, Kellner Á, Karádi É, Valasinyószki E, Udvardy M, Egyed M.

Orv Hetil. 2017 Jun;158(23):901-909. doi: 10.1556/650.2017.30766. Hungarian.

PMID:
28580853
7.

[An audit of the Hungarian Philadelphia negative chronic myeloproliferative neoplasia registry. Evaluation of the essential thrombocythaemic patients].

Dombi P, Illés Á, Demeter J, Homor L, Simon Z, Udvardy M, Karádi É, Kellner Á, Egyed M.

Orv Hetil. 2017 Jan;158(3):111-116. doi: 10.1556/650.2017.30638. Hungarian.

PMID:
28110571
8.

Evaluation of Mannose-Binding Lectin is a Useful Approach to Predict the Risk of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation.

Radnay ZB, Udvardy M, Papp M, Hársfalvi J, Rejto L, Pál I, Illés Á, Kiss A.

Transplant Proc. 2016 Dec;48(10):3397-3405. doi: 10.1016/j.transproceed.2016.08.041.

PMID:
27931588
9.

Anagrelide reduces thrombotic risk in essential thrombocythaemia vs. hydroxyurea plus aspirin.

Dombi P, Illés Á, Demeter J, Homor L, Simon Z, Karadi E, Udvardy M, Egyed M.

Eur J Haematol. 2017 Feb;98(2):106-111. doi: 10.1111/ejh.12806. Epub 2016 Sep 19.

PMID:
27557754
10.

[Drug treatment of acute myelogenous leukaemia. Current options and future perspectives].

Telek B, Rejtő L, Batár P, Miltényi Z, Reményi G, Simon Z, Ujj Z, Mezei G, Szász R, Kiss A, Udvardy M, Illés Á.

Orv Hetil. 2016 May 29;157(22):843-8. doi: 10.1556/650.2016.30433. Review. Hungarian.

PMID:
27211353
11.

Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma.

Magyari F, Barna S, Husi K, Simon Z, Miltényi Z, Váróczy L, Udvardy M, Illés Á.

Hematology. 2016 Aug;21(7):404-10. doi: 10.1080/10245332.2015.1115192. Epub 2016 Mar 1.

PMID:
26907830
12.

Phase III, randomized study of ofatumumab versus physicians' choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia.

Österborg A, Udvardy M, Zaritskey A, Andersson PO, Grosicki S, Mazur G, Kaplan P, Steurer M, Schuh A, Montillo M, Kryachok I, Middeke JM, Kulyaba Y, Rekhtman G, Gorczyca M, Daly S, Chang CN, Lisby S, Gupta I.

Leuk Lymphoma. 2016 Sep;57(9):2037-46. doi: 10.3109/10428194.2015.1122783. Epub 2016 Jan 19.

PMID:
26784000
13.

[Development of the registry for Philadelphia-negative chronic myeloproliferative neoplasia in Hungary].

Dombi P, Illés Á, Demeter J, Homor L, Simon Z, Udvardy M, Egyed M.

Orv Hetil. 2016 Jan 17;157(3):98-103. doi: 10.1556/650.2016.30340. Hungarian.

PMID:
26750731
14.

WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors.

Ujj Z, Buglyó G, Udvardy M, Beyer D, Vargha G, Biró S, Rejtő L.

Pathol Oncol Res. 2016 Jan;22(1):217-21. doi: 10.1007/s12253-015-0002-0. Epub 2015 Nov 4.

PMID:
26531831
15.

[Novel treatment options in relapsed and refracter Hodgkin lymphomas].

Illés Á, Jóna Á, Simon Z, Udvardy M, Miltényi Z.

Orv Hetil. 2015 Nov 8;156(45):1824-33. doi: 10.1556/650.2015.30260. Hungarian.

PMID:
26522856
16.

Histopathological difficulties in an adolescent lymphoma patient.

Magyari F, Barna S, Miltényi Z, Rajnai H, Csomor J, Udvardy M, Illés Á, Váróczy L.

Pathol Oncol Res. 2015 Jan;21(1):213-7. doi: 10.1007/s12253-014-9810-x. Epub 2014 Jul 2.

PMID:
24985032
17.

[Treatment of acute myeloid leukemia -- a single center experience (2007-2013)].

Selmeczi A, Udvardy M, Illés A, Telek B, Kiss A, Batár P, Reményi G, Szász R, Ujj Z, Márton A, Ujfalusi A, Hevessy Z, Pinczés L, Bedekovics J, Rejtő L.

Orv Hetil. 2014 Apr 27;155(17):653-8. doi: 10.1556/OH.2014.29884. Hungarian.

PMID:
24755447
18.

Interaction of factor XIII subunits.

Katona E, Pénzes K, Csapó A, Fazakas F, Udvardy ML, Bagoly Z, Orosz ZZ, Muszbek L.

Blood. 2014 Mar 13;123(11):1757-63. doi: 10.1182/blood-2013-10-533596. Epub 2014 Jan 9.

PMID:
24408323
19.

WT1 overexpression affecting clinical outcome in non-hodgkin lymphomas and adult acute lymphoblastic leukemia.

Ujj Z, Buglyó G, Udvardy M, Vargha G, Biró S, Rejtő L.

Pathol Oncol Res. 2014 Jul;20(3):565-70. doi: 10.1007/s12253-013-9729-7. Epub 2013 Dec 28.

PMID:
24374862
20.

[Waldenström macroglobulinemia].

Telek B, Batár P, Váróczy L, Gergely L, Rejtő L, Szász R, Miltényi Z, Simon Z, Udvardy M, Illés A.

Orv Hetil. 2013 Dec 1;154(50):1970-4. doi: 10.1556/OH.2013.29776. Hungarian.

PMID:
24317355
21.

High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.

Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-Szalmas P.

J Hepatol. 2013 Sep;59(3):457-66. doi: 10.1016/j.jhep.2013.04.018. Epub 2013 Apr 29.

PMID:
23639483
22.

Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment.

Reményi G, Szász R, Debreceni IB, Szarvas M, Batár P, Nagy B Jr, Kappelmayer J, Udvardy M.

Platelets. 2013;24(6):486-92. doi: 10.3109/09537104.2012.731112. Epub 2012 Dec 5.

PMID:
23216455
23.

European perspective on multiple myeloma treatment strategies: update following recent congresses.

Ludwig H, Avet-Loiseau H, Bladé J, Boccadoro M, Cavenagh J, Cavo M, Davies F, de la Rubia J, Delimpasi S, Dimopoulos M, Drach J, Einsele H, Facon T, Goldschmidt H, Hess U, Mellqvist UH, Moreau P, San-Miguel J, Sondergeld P, Sonneveld P, Udvardy M, Palumbo A.

Oncologist. 2012;17(5):592-606. doi: 10.1634/theoncologist.2011-0391. Epub 2012 May 9. Review. Erratum in: Oncologist. 2012;17(7):1005.

24.

Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay.

Hevessy Z, Hudák R, Kiss-Sziráki V, Antal-Szalmás P, Udvardy M, Rejtő L, Szerafin L, Kappelmayer J.

Clin Chem Lab Med. 2011 Dec 17;50(4):689-92. doi: 10.1515/cclm.2011.834.

PMID:
22505532
25.

Complement activation in thrombotic thrombocytopenic purpura.

Réti M, Farkas P, Csuka D, Rázsó K, Schlammadinger Á, Udvardy ML, Madách K, Domján G, Bereczki C, Reusz GS, Szabó AJ, Prohászka Z.

J Thromb Haemost. 2012 May;10(5):791-8. doi: 10.1111/j.1538-7836.2012.04674.x.

26.

[Current treatment of acute myeloid leukaemia in adults].

Telek B, Rejto L, Kiss A, Batár P, Reményi G, Szász R, Ujj ZÁ, Udvardy M.

Orv Hetil. 2012 Feb 19;153(7):243-9. doi: 10.1556/OH.2012.29304. Review. Hungarian.

PMID:
22318524
27.

Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections.

Papp M, Vitalis Z, Altorjay I, Tornai I, Udvardy M, Harsfalvi J, Vida A, Kappelmayer J, Lakatos PL, Antal-Szalmas P.

Liver Int. 2012 Apr;32(4):603-11. doi: 10.1111/j.1478-3231.2011.02689.x. Epub 2011 Dec 6.

PMID:
22145664
28.

Detection of internal tandem duplications in the FLT3 gene by different electrophoretic methods.

Bubán T, Koczok K, Földesi R, Szabó G, Sümegi A, Tanyi M, Szerafin L, Udvardy M, Kappelmayer J, Antal-Szalmás P.

Clin Chem Lab Med. 2011 Nov 4;50(2):301-10. doi: 10.1515/CCLM.2011.762.

PMID:
22053959
29.

Successful administration of rituximab-bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation.

Magyari F, Simon Z, Barna S, Udvardy M, Váróczy L, Illés Á.

Hematol Oncol. 2012 Jun;30(2):98-100. doi: 10.1002/hon.1004. Epub 2011 Oct 28.

PMID:
22034208
30.

[Complementary therapies--based on the principles of evidence-based medicine. Position statement of the Medical Sciences Section of the Hungarian Academy of Sciences].

Medical Sciences Section, Hungarian Academy of Sciences, Dobozy A, Kerpel-Fronius S, Komoly S, Kovács L G, Mandl J, Muszbek L, Petrányi G, Sótonyi P, Udvardy M, Varró A, Vécsei L.

Orv Hetil. 2011 Jul 24;152(30):1197-204. doi: 10.1556/OH.2011.29171. Hungarian. No abstract available.

PMID:
21733793
31.

Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells.

Altorjay I, Veréb Z, Serfozo Z, Bacskai I, Bátori R, Erdodi F, Udvardy M, Sipka S, Lányi Á, Rajnavölgyi É, Palatka K.

Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):323-35.

PMID:
21658307
32.

[Practical considerations and questions in the treatment of chronic lymphocytic leukemia].

Telek B, Rejto L, Batár P, Reményi G, Szász R, Kiss A, Udvardy M.

Orv Hetil. 2011 Jun 12;152(24):958-63. doi: 10.1556/OH.2011.29135. Review. Hungarian.

PMID:
21609922
33.

Multiple myeloma treatment strategies with novel agents in 2011: a European perspective.

Ludwig H, Beksac M, Bladé J, Cavenagh J, Cavo M, Delforge M, Dimopoulos M, Drach J, Einsele H, Facon T, Goldschmidt H, Harousseau JL, Hess U, Kropff M, Leal da Costa F, Louw V, Magen-Nativ H, Mendeleeva L, Nahi H, Plesner T, San-Miguel J, Sonneveld P, Udvardy M, Sondergeld P, Palumbo A.

Oncologist. 2011;16(4):388-403. doi: 10.1634/theoncologist.2010-0386. Epub 2011 Mar 26. Review.

34.

Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis.

Vitalis Z, Altorjay I, Tornai I, Palatka K, Kacska S, Palyu E, Tornai D, Udvardy M, Harsfalvi J, Dinya T, Veres G, Lakatos PL, Papp M.

Hum Immunol. 2011 Apr;72(4):348-54. doi: 10.1016/j.humimm.2011.01.008. Epub 2011 Jan 21.

PMID:
21262313
35.

Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

Papp M, Norman GL, Vitalis Z, Tornai I, Altorjay I, Foldi I, Udvardy M, Shums Z, Dinya T, Orosz P, Lombay B Jr, Par G, Par A, Veres G, Csak T, Osztovits J, Szalay F, Lakatos PL.

PLoS One. 2010 Sep 23;5(9):e12957. doi: 10.1371/journal.pone.0012957.

36.

Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.

Lakatos PL, Kiss LS, Palatka K, Altorjay I, Antal-Szalmas P, Palyu E, Udvardy M, Molnar T, Farkas K, Veres G, Harsfalvi J, Papp J, Papp M.

Inflamm Bowel Dis. 2011 Mar;17(3):767-77. doi: 10.1002/ibd.21402. Epub 2010 Sep 23.

PMID:
20865702
37.

[Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"].

Dávid M, Losonczy H, Udvardy M, Boda Z, Blaskó G, Tar A, Pfliegler G.

Orv Hetil. 2010 Aug 22;151(34):1365-74. doi: 10.1556/OH.2010.28944. Hungarian.

PMID:
20705551
38.

[Successful treatment of B-cell prolymphocytic leukemia (B-PLL) with FCR-Lite (fludarabine, cyclophosphamide, rituximab) protocol].

Telek B, Batár P, Rejto L, Udvardy M.

Orv Hetil. 2010 Aug 1;151(31):1261-3. doi: 10.1556/OH.2010.28917. Hungarian.

PMID:
20656663
39.

Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis.

Altorjay I, Vitalis Z, Tornai I, Palatka K, Kacska S, Farkas G, Udvardy M, Harsfalvi J, Dinya T, Orosz P, Lombay B Jr, Par G, Par A, Csak T, Osztovits J, Szalay F, Csepregi A, Lakatos PL, Papp M.

J Hepatol. 2010 Sep;53(3):484-91. doi: 10.1016/j.jhep.2010.03.028. Epub 2010 Jun 2.

PMID:
20605050
40.

Treatment of mantle cell lymphoma with autologous stem-cell transplantation in a patient with severe congenital haemophilia-A and chronic (B and C virus) hepatitis.

Rejto L, Schlammadinger A, Ilonczai P, Tornai I, Batar P, Remenyi G, Kiss A, Udvardy M.

Haemophilia. 2010 Jul 1;16(4):706-7. doi: 10.1111/j.1365-2516.2010.02243.x. Epub 2010 Apr 7. No abstract available.

PMID:
20398068
41.

Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.

Papp M, Lakatos PL, Harsfalvi J, Farkas G, Palatka K, Udvardy M, Molnar T, Farkas K, Nagy F, Veres G, Lakatos L, Kovacs A, Dinya T, Kocsis AK, Papp J; Hungarian IBD Study Group, Altorjay I.

Hum Immunol. 2010 Apr;71(4):407-13. doi: 10.1016/j.humimm.2010.01.012. Epub 2010 Jan 26.

PMID:
20079790
42.

[Therapy of mantle cell lymphoma].

Udvardy M.

Orv Hetil. 2009 Dec 13;150(50):2253-7. doi: 10.1556/OH.2009.28763. Review. Hungarian.

PMID:
19951856
43.

Anti-microbial antibodies in celiac disease: trick or treat?

Papp M, Foldi I, Altorjay I, Palyu E, Udvardy M, Tumpek J, Sipka S, Korponay-Szabo IR, Nemes E, Veres G, Dinya T, Tordai A, Andrikovics H, Norman GL, Lakatos PL.

World J Gastroenterol. 2009 Aug 21;15(31):3891-900.

44.

Novel evaluation method for densitometric curves of von Willebrand factor multimers and a new parameter (M(MW)) to describe the degree of multimersation.

Udvardy ML, Szekeres-Csiki K, Hársfalvi J.

Thromb Haemost. 2009 Aug;102(2):412-7. doi: 10.1160/TH09-01-0032.

PMID:
19652894
45.

[One hundred fifty autologous peripheral haemopoietic stem cell transplantations and their lessons].

Kiss A, Reményi G, Szász R, Batár P, Rejto L, Váróczy L, Sípos T, Kovácsné Kovács E, Szarvas M, Udvardy M.

Orv Hetil. 2009 Jul 5;150(27):1251-7. doi: 10.1556/OH.2009.28557. Hungarian.

PMID:
19531458
46.

[Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression].

Bedekovics J, Rejto L, Telek B, Udvardy M, Ujfalusi A, Oláh E, Hevessy Z, Kappelmayer J, Kajtár B, Méhes G.

Orv Hetil. 2009 May 31;150(22):1031-5. doi: 10.1556/OH.2009.28623. Hungarian.

PMID:
19465351
47.

Increased platelet glycoprotein Ib receptor number, enhanced platelet adhesion and severe cerebral ischaemia in a patient with polycythaemia vera.

Toth J, Kappelmayer J, Udvardy ML, Szanto T, Szarvas M, Rejto L, Soltesz P, Udvardy M, Harsfalvi J.

Platelets. 2009 Jun;20(4):282-7. doi: 10.1080/09537100902878421.

PMID:
19459135
48.

[Transformation of chronic lymphocytic leukemia to myelodysplastic syndrome: case presentation and review of the literature].

Telek B, Pfliegler G, Reményi G, Méhes L, Batár P, Udvardy M.

Orv Hetil. 2009 Apr 12;150(15):689-92. doi: 10.1556/OH.2009.28597. Review. Hungarian.

PMID:
19362917
49.

Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.

Papp M, Altorjay I, Lakos G, Tumpek J, Sipka S, Dinya T, Palatka K, Veres G, Udvardy M, Lakatos PL.

Clin Vaccine Immunol. 2009 Apr;16(4):464-70. doi: 10.1128/CVI.00002-09. Epub 2009 Feb 4.

50.

Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.

Molvarec A, Rigó J Jr, Bõze T, Derzsy Z, Cervenak L, Makó V, Gombos T, Udvardy ML, Hársfalvi J, Prohászka Z.

Thromb Haemost. 2009 Feb;101(2):305-11.

PMID:
19190814

Supplemental Content

Loading ...
Support Center